Rapid quantitative screening of bispecific antibodies using Protein A and HIS1K biosensors
Recent advances in biotechnology have fueled the development of bispecific antibodies, but for those working in bioprocessing or cell line screening, there still remains a number of development challenges. Many traditional technologies for characterizing antibodies are limited in their ability to provide quantitative functional assessment of two interactions to one bispecific molecule, and commonly used assay platforms like ELISA and SPR are time-intensive. Scientists at Celgene Corporation developed a screening process incorporating the Octet® RH96 system to identify pools and clones with higher concentrations of bispecific antibodies. Higher throughput on the Octet system was achieved from the multiple simultaneous measures possible on the system and rapid assays times, such as binding optimization in only 10 minutes.
Download our application note to learn how you can minimize time, effort, and cost when screening bispecific candidates.
Get the Latest Updates, Trends and Developments on Label-free, Stress-Free Solutions for Drug Discovery, Biologics Development and Biomanufacturing.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now